China Nuokang Bio-Pharmaceutical Inc. IPO Prices Below Range, Raises $45 Million

Published: Dec 10, 2009

Bookmark and Share

Reuters -- China Nuokang Bio-Pharmaceutical Inc priced shares in its initial public offering at a lower-than-expected $9 each on Wednesday, raising about $45 million, the issue's underwriter said.

Back to news